For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>

Cadila Pharmaceuticals in the News

November 25 2016
CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza

May 29, 2016
Free medical camp by Kaka-Ba Hospital and Cadila Pharmaceuticals to provide healthcare support to locals

November 27, 2015
Kaka-Ba Hospital, Hansot organises free of cost plastic & pediatric dental surgeries using special surgical methods

September 21, 2015
Free medical camp organised at Transad village of Dholka, Ahmedabad by Kaka-Ba Hospital in association with Cadila Pharmaceuticals

June 28, 2015
Kaka-Ba Hospital and Cadila Pharmaceuticals organised free medical camp to provide healthcare support to locals

November, 2015
Geeta stara

September 29, 2015
Kaka-Ba Hospital accomplish 100 free of cost surgeries to the needy patients of medical camps

March 23, 2015
Cadila Pharmaceuticals to observe World TB Day Multi-city activities to raise awareness on killer disease
India Today
Sep, 2014
Dial India for investment at India Today Global Roundtable

Dr. Rajiv Modi speaks at the India Today Roundtable , Dial India for investment sesion.

Business Standard
Sep 09, 2014
Cadila Pharma plans for manufacturing facility in Bahrain

The Gujarat-based generic drug manufacturer Cadila Pharmaceuticals is reportedly exploring possibility of setting up a manufacturing facility in Bahrain. “We are scouting for partners with strong local presence and credentials in the industry or allied activities,” Cadila Chairman and Managing Director Dr. Rajiv Modi told the newspaper.

Gulf Daily News
Sep 07, 2014
Drugs firm eyes Bahrain plant

Cadila Pharmaceuticals, one of the largest privately held pharmaceutical companies in India, is exploring partnerships for a manufacturing facility in Bahrain, the company’s chairman and managing director Dr Rajiv Modi told the GDN in an exclusive interview.

Hindu Businessline
July 10, 2014
Setting up labs a noteworthy step: Cadila Pharma

Decision to set up new drug testing laboratories and strengthening the 31 existing State laboratories is a noteworthy step which will provide assistance to the States’ Drug Regulatory and Food Regulatory Systems says Rajiv Modi, Chairman and Managing Director, Cadila Pharmaceuticals.

Asian Age | The Economic Times
June, 2014
Cadila Pharmaceuticals Limited adopts Eco friendly measures


April, 2014
Dr.Rajiv Modi – Collaborative Indigenous effort key to R&D success
Business Standard
Jan 28, 2014
Carrying the legacy forward: Rajiv Modi. Modi continues to focus on producing innovative drugs at affordable prices

Modi continues to focus on producing innovative drugs at affordable prices
The company that started in a rented bungalow with a capital of Rs 25,000 and achieved a turnover of around Rs 1.25 lakh in its first year of operation has come a long way: it has three innovative medicines to its credit – Polycap (for prevention and treatment of cardiovascular diseases), Risorine (for treatment of tuberculosis) and the recently introduced Mycidac-C, the world’s first active immuno therapy in lung cancer.

Jan 27, 2014
Dr.Rajiv Modi – Chairman and Managing Director of Cadila Pharmaceuticals Limited named ‘Chitralekha Business Person of the Year’
Pharma Bio World
December, 2013
“Our mission has been to offer even our innovative molecules at an affordable price.”

Dr Rajiv Modi, CMD, Cadila Pharmaceuticals in an interview with Ananya Sen discusses Cadila’s innovation Mycidiac-C and their new research partnership.

The Times of India
Nov 16, 2013
Cadila Pharmaceuticals signs licensing deal with UK’s Helperby Therapeutics

AHMEDABAD: Cadila Pharmaceuticals and UK-based antibiotics discovery major, Helperby Therapeutics have signed a joint agreement on Antibiotic Drug Resistance Research & Development.

Live Mint & The Wall Street Journal
Nov 15, 2013
Cadila Pharma, Helperby sign deal for antibiotic drug licensing

The tie-up, formalised during British Prime Minister David Cameron’s one-day visit to India on Thursday, will focus on the discovery of patented ‘resistance breaker’ compounds, the Ahmedabad-based Cadila said in a release on Thursday.

Business Standard
November 14, 2013
Cadila Pharma signs licensing deal with UK’s Helperby

Ahmedabad-based privately held pharma major Cadila Pharmaceuticals Limited and UK based antibiotics discovery major Helperby Therapeutics have signed a joint agreement on antibiotic drug resistance research & development.

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals